NASDAQ:DBTX

Decibel Therapeutics (DBTX) News Today

$5.03

+2.24 (+80.29%)

(As of 08/9/2023 ET)

Compare

Today's Range: $4.73
▼
$5.09
50-Day Range: $2.76
▼
$4.81
52-Week Range: $1.61
▼
$5.68

Volume: 6.02 million shs
Average Volume: 96,050 shs
Market Capitalization: $125.83 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $9.25

Source

Source	Headline
	Complaints about airplane noise rise at Reagan National, Dulles washingtonpost.com - August 9 at 9:34 PM
	Regeneron to acquire gene therapy developer Decibel for $4 per share msn.com - August 9 at 9:34 PM
	Decibel Therapeutics (NASDAQ:DBTX) Skyrockets On Acquisition By Regeneron msn.com - August 9 at 9:34 PM
	Shareholder Alert: Ademi LLP investigates whether Decibel Therapeutics, Inc. has obtained a Fair Price in its transaction with Regeneron benzinga.com - August 9 at 4:33 PM
	Regeneron to Acquire Decibel Therapeutics, Strengthening Gene Therapy and Hearing Loss Programs finance.yahoo.com - August 9 at 10:40 AM
	marketbeat.com - August 9 at 7:30 AM
	DBTX - Decibel Therapeutics, Inc. finance.yahoo.com - July 21 at 12:50 PM
	Robert W. Baird Reaffirms Their Buy Rating on Decibel Therapeutics (DBTX) markets.businessinsider.com - June 22 at 9:21 AM
	H.C. Wainwright Reaffirms Their Buy Rating on Decibel Therapeutics (DBTX) markets.businessinsider.com - June 6 at 7:42 AM
	Decibel Therapeutics to Participate in the Upcoming Jefferies Healthcare Conference finance.yahoo.com - June 2 at 11:05 AM
	Decibel Therapeutics to Present DB-020 Phase 1b Clinical Trial Data at the American Society of Clinical Oncology (ASCO) 2023 Annual Meeting finance.yahoo.com - June 1 at 7:41 PM
	SVB Securities Sticks to Its Hold Rating for Decibel Therapeutics (DBTX) markets.businessinsider.com - May 29 at 4:51 PM
	Decibel Therapeutics to Participate in the Upcoming Barclays 2023 Gene Editing and Gene Therapy Summit finance.yahoo.com - May 17 at 5:20 PM
	Decibel Therapeutics Reports First Quarter 2023 Financial Results and Corporate Update finance.yahoo.com - May 15 at 11:00 AM
	HC Wainwright & Co. Reiterates Decibel Therapeutics (DBTX) Buy Recommendation msn.com - May 13 at 8:33 AM
	Decibel Therapeutics Announces Approval of Clinical Trial Application by the Spanish Agency of Medicines and Medical Devices (AEMPS) to Initiate Clinical Development of Lead Gene Therapy Candidate DB-OTO finance.yahoo.com - May 12 at 7:26 AM
	Db Insurance forbes.com - May 10 at 10:57 PM
	Decibel Therapeutics to Present at the American Society of Gene and Cell Therapy (ASGCT) 26th Annual Meeting finance.yahoo.com - May 10 at 5:57 PM
	Decibel Therapeutics Receives European Orphan Drug Designation for Lead Gene Therapy Candidate DB-OTO finance.yahoo.com - March 30 at 7:59 AM
	Decibel Therapeutics to Participate in the Upcoming Guggenheim Healthcare Talks \| Genomic Medicines and Rare Disease Days finance.yahoo.com - March 28 at 5:45 PM
	Decibel Therapeutics Appoints Matthew Kapusta to its Board of Directors finance.yahoo.com - March 21 at 10:41 AM
	Decibel Therapeutics, Inc.: Decibel Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Corporate Update finanznachrichten.de - March 19 at 10:57 AM
	SVB Leerink Downgrades Decibel Therapeutics (DBTX) msn.com - March 16 at 8:11 AM
	Decibel Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Corporate Update finance.yahoo.com - March 14 at 8:31 PM
	private equity firms who own 39% along with institutions invested in Decibel Therapeutics, Inc. (NASDAQ:DBTX) saw increase in their holdings value last week finance.yahoo.com - March 2 at 2:50 PM
	Decibel Therapeutics to Present at the Upcoming SVB Securities Global Biopharma Conference finance.yahoo.com - February 16 at 8:00 AM
	Decibel Therapeutics to Present at the 46th Annual Association for Research in Otolaryngology (ARO) MidWinter Meeting finance.yahoo.com - February 9 at 9:28 AM
	2 “Strong Buy” Penny Stocks That Could Rally All the Way to $11 (or More) finance.yahoo.com - February 8 at 2:19 PM
	Decibel, Regeneron get UK regulator nod to start trial of hearing loss gene therapy msn.com - January 24 at 9:52 AM
	Decibel Therapeutics Announces Approval of Clinical Trial Application by the U.K. Medicines and Healthcare Products Regulatory Agency for Lead Gene Therapy Candidate DB-OTO finance.yahoo.com - January 24 at 9:52 AM
	Will Decibel Therapeutics (NASDAQ:DBTX) Spend Its Cash Wisely? finance.yahoo.com - January 20 at 2:33 PM
	Noise pollution is a menace to humanity – and a deadly threat to animals theguardian.com - January 11 at 8:26 PM
	Why Broadwind Shares Are Trading Higher By 85%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session msn.com - January 11 at 3:25 PM
	marketbeat.com - December 29 at 9:35 AM
	SVB Securities Keeps Their Buy Rating on Decibel Therapeutics (DBTX) markets.businessinsider.com - November 14 at 2:45 AM
	Decibel Therapeutics, Inc.: Decibel Therapeutics Reports Third Quarter 2022 Financial Results and Corporate Update finanznachrichten.de - November 10 at 4:13 PM
	Decibel Therapeutics Reports Third Quarter 2022 Financial Results and Corporate Update finance.yahoo.com - November 9 at 8:48 PM
	Decibel Therapeutics Announces Submission of Clinical Trial Applications for Lead Gene Therapy Candidate DB-OTO finance.yahoo.com - November 2 at 6:16 PM
	Equities Analysts Offer Predictions for Decibel Therapeutics, Inc.'s Q4 2022 Earnings (NASDAQ:DBTX) marketbeat.com - October 27 at 8:50 AM
	Decibel Therapeutics hears it may be a takeout target after Lilly acquisition of Akouos seekingalpha.com - October 18 at 12:16 PM
	Decibel Therapeutics Receives FDA Clearance of IND Application for DB-OTO, a Gene Therapy Product Candidate Designed to Provide Hearing to Individuals with Otoferlin-Related Hearing Loss finance.yahoo.com - October 17 at 10:06 AM
	Save $100 on Bose noise-canceling headphones during the Amazon Prime Early Access sale usatoday.com - October 14 at 3:17 PM
	Decibel Therapeutics Appoints Kevin F. McLaughlin to its Board of Directors finance.yahoo.com - October 12 at 8:12 AM
	Decibel Therapeutics, Inc. (NASDAQ:DBTX) Receives Consensus Recommendation of "Buy" from Analysts marketbeat.com - September 28 at 2:04 AM
	HC Wainwright Reaffirms Buy Rating for Decibel Therapeutics (NASDAQ:DBTX) marketbeat.com - September 21 at 12:06 PM
	Decibel Therapeutics Announces Submission of Investigational New Drug (IND) Application for Lead Gene Therapy Candidate DB-OTO finance.yahoo.com - September 20 at 7:51 PM
	We Think Decibel Therapeutics (NASDAQ:DBTX) Needs To Drive Business Growth Carefully nasdaq.com - August 30 at 11:17 AM
	Decibel Therapeutics, Inc. (NASDAQ:DBTX) Receives Consensus Rating of "Buy" from Analysts marketbeat.com - August 29 at 4:14 AM
	Decibel Therapeutics (DBTX) Investor Presentation - Slideshow seekingalpha.com - August 16 at 11:21 PM
	Here's Why We're Watching Decibel Therapeutics' (NASDAQ:DBTX) Cash Burn Situation finance.yahoo.com - August 13 at 3:29 PM

Get Decibel Therapeutics News Delivered to You Automatically

DBTX Media Mentions By Week

DBTX Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

DBTX
News Sentiment
▼
-0.45

0.42
▲
Average
Medical
News Sentiment

DBTX News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

DBTX Articles
This Week
▼
7

1
▲
DBTX Articles
Average Week

Get Decibel Therapeutics News Delivered to You Automatically

Related Companies and Tools

Related Companies:

Headlines Tools:

This page (NASDAQ:DBTX) was last updated on 8/10/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Decibel Therapeutics (DBTX) News Today

DBTX Media Mentions By Week

DBTX Media Sentiment

DBTX News Coverage

Related Companies and Tools

About MarketBeat

Popular Tools

Financial Calendars

Terms & Info